TerraLIX is a manufacturer specializing in hydrogen fuel cells and related products. The company focuses on developing fuel cell systems that can operate effectively in extreme environments, ensuring reliable energy sources even under challenging conditions. By providing advanced cell packs, TerraLIX aims to meet the growing demand for sustainable energy solutions in various applications.
Mom-sitter
Seed Round in 2019
Mom-sitter is a childcare platform based in Seoul, Korea, designed to connect parents with caregivers for children aged 0 to 13 years. The platform facilitates the matching process by providing detailed information about caregivers, including their specialties and legal backgrounds, to ensure that parents can make informed decisions. By assessing the needs of families seeking childcare services, Mom-sitter aims to match them with qualified babysitting professionals, thereby enhancing trust and safety in the babysitting experience.
InkHunter
Convertible Note in 2016
InkHunter, Inc. is a company that develops a mobile application utilizing augmented reality to assist tattoo artists and enthusiasts in visualizing tattoo designs. Founded in 2014 and headquartered in New York, the application allows users to project tattoo designs onto any part of their body in real-time, helping them to assess size and placement before making a permanent decision. Users can select designs from a gallery or upload their own creations, and they have the ability to resize and reposition the tattoos from various angles. The app also enables users to edit photos and share their tattoo designs with friends, enhancing the overall experience of selecting a tattoo.
Intarcia Therapeutics
Series E in 2016
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.
Harrington Re
Venture Round in 2016
Harrington Re Ltd. is a Bermuda-based multi-line reinsurance company, jointly sponsored by AXIS Capital Holdings and Blackstone Group. Registered as a Class 4 Insurer with the Bermuda Monetary Authority, it operates with total capital of approximately $600 million, which includes $50 million in senior debt. The company provides reinsurance services across a diverse range of property and casualty lines globally. By combining its multi-line reinsurance portfolio with a diversified set of alternative investments, Harrington Re aims to generate risk-adjusted equity returns for its shareholders. The company has also received an A- (“Excellent”) financial strength rating from A.M. Best, reflecting its solid financial standing.
Lateral Investment Management
Venture Round in 2014
Lateral Investment Management, established in 2014, is a California-based private equity firm specializing in providing financing solutions to middle market and lower middle market companies, particularly owner-operated and family-owned businesses. The firm offers bridge financing, acquisition financing, and non-dilutive growth capital, focusing on the manufacturing, healthcare, infrastructure, and technology sectors across the United States. Lateral invests between $10 million to $50 million in growth capital and up to $75 million in structured financing, typically seeking a minority stake and aiming for a one to three-year exit. The firm, headquartered in San Mateo with an additional office in New York, provides financing in the form of loans, without taking ownership or control of the businesses it supports.
Symbiont
Seed Round in 2014
Symbiont.io, Inc. is a financial technology company that specializes in developing a smart contracts platform tailored for institutional applications of blockchain technology. Founded in 2013 and headquartered in New York City, with an additional office in Amsterdam, the company provides a comprehensive infrastructure for capital markets. This includes a unified ledger for sharing business logic and market data, as well as the Symbiont Assembly platform, which facilitates the issuance, tracking, and management of financial instruments such as loans, securities, and commodities. By enabling complex financial instruments to exist within a decentralized blockchain network, Symbiont aims to enhance transparency, reduce risk, and lower costs for financial institutions and government entities. The company has established partnerships with industry leaders, including Vanguard and the State of Delaware, to drive innovation and improve operational efficiency in the capital markets sector.
Fundation
Series A in 2013
Fundation Group LLC, established in 2011 and headquartered in Reston, Virginia, specializes in developing and providing a digital credit lending platform. This platform connects financial institutions with small businesses, facilitating access to working capital and growth capital. Fundation partners with banks and other institutions, offering outsourced lending and referral programs, along with point-of-sale financing solutions. The company's mission is to empower the small business economy by enabling critical institutions to better serve their small business clients through technology and advanced analytics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.